Form D · Other Technology
Symbiont.io, Inc.
New York, NY · CIK 0001647548
Offering snapshot reported Jan 24, 2019 · SEC filing
- Reported sold
- $21.5M Offering amount: $23M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jan 2, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 24, 2019 | Initial | $21,506,978 | No comparison | 23 | SEC filing |
| Jul 16, 2015 | Initial | $1,235,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-331227
Source: Form D, filed Jan 24, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Dermody | Director, Executive |
| Neil De Sena | Director |
| Dan Gallagher | Director |
| Shivan Govindan | Director |
| Jack Markell | Director |
| Duncan Niederauer | Director |
| Todd Ruppert | Director |
| Mark Smith | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
632 Broadway 5 Th Floor
New York, NY, 10012
New York, NY, 10012